封面
市场调查报告书
商品编码
1624399

软骨修復-软骨再生全球市场规模(按应用、治疗方式、地区、范围和预测)

Global Cartilage Repair-Cartilage Regeneration Market Size By Application, By Treatment Modality, By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

软骨修復 - 软骨再生的市场规模与预测

2019 年软骨修復 - 软骨再生市场规模价值 6.0065 亿美元,预计到 2027 年将达到 15.3569 亿美元,2020 年至 2027 年的复合年增长率为 13.43%。

预计未来几年骨关节炎等骨骼和关节疾病的增加、运动伤害的增加以及软骨再生技术的进步将推动软骨修復再生市场的发展。软骨修復-软骨再生全球市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球软骨修復-软骨再生市场

软骨修復 - 软骨再生是一种关节治疗,可以使软骨恢復健康但受损。软骨可能因受伤而受损,促使功能障碍和疼痛。缺乏血液供应是软骨损伤的原因之一。

透过早期采用软骨修復或再生方法可以预防骨关节炎的发展。依应用不同,分为软骨修復与再生、纤维软骨修復与再生。有许多类型的治疗方法,包括基于细胞的方法、软骨细胞移植、生长因子技术、干细胞、非基于细胞的方法、组织支架和无细胞复合材料。

软骨修復 – 软骨再生的全球市场概况

预计骨关节炎等骨骼和关节疾病盛行率的上升以及软骨再生技术的进步将在未来几年推动软骨修復再生市场的发展。此外,老年人口的增加和运动伤害数量的增加预计将在未来几年推动市场的发展。此外,预计在预测期内糖尿病盛行率的上升将推动市场的发展。也有一些因素和课题阻碍了市场成长。不利的报销情况和治疗费用上升等因素可能会对市场产生限製作用。

目录

第 1 章 软骨修復与再生:全球市场介绍

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章:经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第4章 全球软骨修復-软骨再生市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析
  • 监理框架

第 5 章软骨修復 - 软骨再生全球市场(按应用)
  • 概述
  • 透明质酸软骨修復与再生
  • 纤维软骨修復与再生

第6章 全球软骨修復与再生市场(依治疗方式划分)

  • 概述
  • 基于细胞的方法
  • 软骨细胞移植 生长因子技术
  • 干细胞
  • 非基于细胞的方法
  • 组织支架
  • 无细胞复合材料

第 7 章软骨修復-软骨再生全球市场(按区域)
  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第 8 章全球软骨修復-软骨再生市场:竞争格局

  • 概述
  • 公司市占率
  • 供应商概况
  • 主要发展策略

第9章 公司简介

  • Zimmer Biomet Holdings, Inc.
  • DepuySynthes(Johnson & Johnson Company)
  • Vericel Corporation
  • Smith & Nephew PLC
  • Osiris Therapeutics, Inc.
  • Arthrex, Inc.
  • RTI Surgical
  • ConmedLinvatec
  • LAnika Therapeutics S. R. L.
  • B. Braun Melsungen AG

第10章 附录

  • 相关调查
简介目录
Product Code: 24169

Cartilage Repair-Cartilage Regeneration Market Size And Forecast

Cartilage Repair-Cartilage Regeneration Market size was valued at USD 600.65 Million in 2019 and is projected to reachUSD 1535.69 Million by 2027, growing at aCAGR of 13.43% from 2020 to 2027.

The rising incidences of bone & joint disorders like osteoarthritis, the growing number of sports injuries, and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. The Global Cartilage Repair-Cartilage Regeneration Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cartilage Repair-Cartilage Regeneration Market Definition

Cartilage Repair-Cartilage Regeneration Is a Joint Treatment for Having Healthy but Damaged Cartilage. the Cartilage Gets Damaged Due to Injury-Causing Impaired Function and Pain. a Direct Blow, Progressive Degeneration, and Traumatic Injury Are Some of The Reasons for Articular Cartilage Injuries. the Progressive Loss of Structure and Function of The Cartilage Causes Degeneration of Cartilage. Lack of Blood Supply Is One of The Reasons for Cartilage Damage.

Development of Osteoarthritis Can Be Prevented by Early Adoption of Cartilage Restoration or Regeneration Methods. Based on The Application, the Market Can Be Classified Into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. Various Types of Treatment Modalities Are Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cartilage Repair-Cartilage Regeneration Market Overview

The rising incidences of bone & joint disorders like osteoarthritis and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. Also, the increasing geriatric population and the growing number of sports injuries expect a boost to the market in the coming years. Additionally, the growing prevalence of diabetes is predicted to fuel the market during the forecasted period. There are certain restraints and challenges faced which can hinder market growth. Factors such as unfavorable reimbursement scenarios and higher costs of therapy are likely to act as market restraints.

Global Cartilage Repair-Cartilage Regeneration Market: Segmentation Analysis

The Global Cartilage Repair-Cartilage Regeneration Market is Segmented on the basis of Application, Treatment Modality, And Geography.

Cartilage Repair-Cartilage Regeneration Market, By Application

  • Hyaline Cartilage Repair and Regeneration
  • Fibrocartilage Repair and Regeneration

Based on Application, the market is bifurcated into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. The Hyaline Cartilage Repair and Regeneration segment is expected to hold the largest market share. The factors can be attributed to the increasing incidents of physical trauma all over the world.

Cartilage Repair-Cartilage Regeneration Market, By Treatment Modality

  • Cell-Based Approaches
  • Chondrocyte Transplantation
  • Growth Factor Technology
  • Stem Cells
  • Non-Cell-Based Approaches
  • Tissue Scaffolds
  • Cell-Free Composites

Based on Treatment Modality, the market is bifurcated into Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites. Cell-Based Approaches are predicted to hold the most significant CAGR in the forecasted period due to the technological advancements in stem cell-based therapies for cartilage repair and chondrocyte implantation products.

Cartilage Repair-Cartilage Regeneration Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on regional analysis, the Global Cartilage Repair-Cartilage Regeneration Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by the Asia Pacific owing to the rise in incidences of various disorders & injuries and the increasing geriatric population in this region.

Key Players

  • The "Global Cartilage Repair-Cartilage Regeneration Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market Such As
  • Zimmer Biomet Holdings, Inc., DepuySynthes (Johnson & Johnson Company), Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., Arthrex, Inc., RTI Surgical, ConmedLinvatec, Anika Therapeutics S. R. L., B. Braun Melsungen AG.
  • These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY APPLICATION

  • 5.1 Overview
  • 5.2 Hyaline Cartilage Repair and Regeneration
  • 5.3 Fibrocartilage Repair and Regeneration

6 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY

  • 6.1 Overview
  • 6.2 Cell-Based Approaches
  • 6.3 Chondrocyte Transplantation
  • 6.4 Growth Factor Technology
  • 6.5 Stem Cells
  • 6.6 Non-Cell-Based Approaches
  • 6.7 Tissue Scaffolds
  • 6.8 Cell-Free Composites

7 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Zimmer Biomet Holdings, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 DepuySynthes (Johnson & Johnson Company)
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Vericel Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Smith & Nephew PLC
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Osiris Therapeutics, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Arthrex, Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 RTI Surgical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ConmedLinvatec
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 LAnika Therapeutics S. R. L.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 B. Braun Melsungen AG
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research